Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Laquinimod for multiple sclerosis.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
Acorda Therapeutics announces top line results of post-marketing commitment study exploring 5 mg dose of dalfampridine-ER
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Ono to enter license agreements with Merck KGaA
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
It is better to be in a clinical trial than not: lessons learnt from clinical neurology--the management of acute multiple sclerosis relapses.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
Double blind placebo-controlled Phase I/II clinical trial of idebenone in patients with primary progressive multiple sclerosis (IPPoMS)
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
Puma, but not noxa is essential for oligodendroglial cell death.
Generic Midamor
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
[Plasmapheresis in central nervous system disorders].
Treatment of multiple sclerosis with anti-CD20 antibodies.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Pages
« first
‹ previous
…
96
97
98
99
100
101
102
103
104
…
next ›
last »